BI-1347
|
|
- CAS号:
- 2163056-91-3
- 英文名:
- None
- 英文别名:
- BI-1347
(BI1347);1H-Pyrazole-1-acetamide, 4-[4-(4-isoquinolinyl)phenyl]-N,N-dimethyl-;2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide;BI-1347,None,2-{4-[4-(isoquinolin-4-yl)phenyl]-1H-pyrazol-1-yl}-N,N-dimethylacetamide;BI1347,oral activity,human NK92MI cell,BI-1347,Inhibitor,CDK,mouse splenic NK cell,BI 1347,anti-tumoral activity,inhibit,Cyclin dependent kinase,selectivity
- 中文名:
- BI-1347
- 中文别名:
- 化合物BI-1347;2-{4-[4-(异喹啉-4-基)苯基]吡唑-1-基}-N,N-二甲基乙酰胺;2- {4- [4-(异喹啉-4-基)苯基] -1H-吡唑-1-基} -N,N-二甲基乙酰胺
- CBNumber:
- CB54656561
- 分子式:
- C22H20N4O
- 分子量:
- 356.42
- MOL File:
- 2163056-91-3.mol
|
|
|
BI-1347化学性质
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO:98.0(Max Conc. mg/mL);274.95(Max Conc. mM)
Ethanol:3.0(Max Conc. mg/mL);8.42(Max Conc. mM)-
|
-
形态:
-
Solid
-
|
-
颜色:
-
Light yellow to yellow
-
|
BI-1347性质、用途与生产工艺
BI-1347是Cyclin-dependent kinase 8(CDK8)的小分子抑制剂,IC50为1.1 nM。
Target | Value |
CDK8
(Cell-free assay)
|
1.1 nM
|
BI-1347
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/08/19 | S1058 | BI-1347 BI-1347 | 2163056-91-3 | 5mg | 1070.28元 |
2024/08/19 | S1058 | BI-1347 | 2163056-91-3 | 10mM (1mL in DMSO) | 1570元 |
2163056-91-3, BI-1347 相关搜索:
- 药靶配体
- 对照品
- 2-{4-[4-(异喹啉-4-基)苯基]吡唑-1-基}-N,N-二甲基乙酰胺
- 化合物BI-1347
- 2- {4- [4-(异喹啉-4-基)苯基] -1H-吡唑-1-基} -N,N-二甲基乙酰胺
- 2163056-91-3
- BI1347,oral activity,human NK92MI cell,BI-1347,Inhibitor,CDK,mouse splenic NK cell,BI 1347,anti-tumoral activity,inhibit,Cyclin dependent kinase,selectivity
- BI-1347,None,2-{4-[4-(isoquinolin-4-yl)phenyl]-1H-pyrazol-1-yl}-N,N-dimethylacetamide
- 2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide
- 1H-Pyrazole-1-acetamide, 4-[4-(4-isoquinolinyl)phenyl]-N,N-dimethyl-
- BI-1347
(BI1347)